rs139034501

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_020822.3(KCNT1):​c.30G>A​(p.Pro10=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00786 in 1,608,588 control chromosomes in the GnomAD database, including 87 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P10P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0052 ( 5 hom., cov: 33)
Exomes 𝑓: 0.0081 ( 82 hom. )

Consequence

KCNT1
NM_020822.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -1.43
Variant links:
Genes affected
KCNT1 (HGNC:18865): (potassium sodium-activated channel subfamily T member 1) Potassium channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a sodium-activated potassium channel subunit which is thought to function in ion conductance and developmental signaling pathways. Mutations in this gene cause the early-onset epileptic disorders, malignant migrating partial seizures of infancy and autosomal dominant nocturnal frontal lobe epilepsy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2012]
SOHLH1 (HGNC:27845): (spermatogenesis and oogenesis specific basic helix-loop-helix 1) This gene encodes one of testis-specific transcription factors which are essential for spermatogenesis, oogenesis and folliculogenesis. This gene is located on chromosome 9. Mutations in this gene are associated with nonobstructive azoospermia. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 9-135702288-G-A is Benign according to our data. Variant chr9-135702288-G-A is described in ClinVar as [Benign]. Clinvar id is 193440.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-135702288-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-1.43 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00522 (795/152156) while in subpopulation SAS AF= 0.0162 (78/4824). AF 95% confidence interval is 0.0133. There are 5 homozygotes in gnomad4. There are 395 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 795 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
KCNT1NM_020822.3 linkuse as main transcriptc.30G>A p.Pro10= synonymous_variant 1/31 ENST00000371757.7
KCNT1NM_001272003.2 linkuse as main transcriptc.30G>A p.Pro10= synonymous_variant 1/31

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
KCNT1ENST00000371757.7 linkuse as main transcriptc.30G>A p.Pro10= synonymous_variant 1/311 NM_020822.3 A2Q5JUK3-3

Frequencies

GnomAD3 genomes
AF:
0.00524
AC:
797
AN:
152038
Hom.:
5
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00123
Gnomad AMI
AF:
0.00989
Gnomad AMR
AF:
0.00465
Gnomad ASJ
AF:
0.0150
Gnomad EAS
AF:
0.00406
Gnomad SAS
AF:
0.0162
Gnomad FIN
AF:
0.000377
Gnomad MID
AF:
0.0350
Gnomad NFE
AF:
0.00719
Gnomad OTH
AF:
0.00527
GnomAD3 exomes
AF:
0.00672
AC:
1581
AN:
235382
Hom.:
9
AF XY:
0.00764
AC XY:
992
AN XY:
129928
show subpopulations
Gnomad AFR exome
AF:
0.00125
Gnomad AMR exome
AF:
0.00370
Gnomad ASJ exome
AF:
0.0157
Gnomad EAS exome
AF:
0.000925
Gnomad SAS exome
AF:
0.0149
Gnomad FIN exome
AF:
0.000424
Gnomad NFE exome
AF:
0.00740
Gnomad OTH exome
AF:
0.00749
GnomAD4 exome
AF:
0.00813
AC:
11846
AN:
1456432
Hom.:
82
Cov.:
32
AF XY:
0.00842
AC XY:
6102
AN XY:
724562
show subpopulations
Gnomad4 AFR exome
AF:
0.00169
Gnomad4 AMR exome
AF:
0.00357
Gnomad4 ASJ exome
AF:
0.0155
Gnomad4 EAS exome
AF:
0.0145
Gnomad4 SAS exome
AF:
0.0146
Gnomad4 FIN exome
AF:
0.000347
Gnomad4 NFE exome
AF:
0.00788
Gnomad4 OTH exome
AF:
0.00788
GnomAD4 genome
AF:
0.00522
AC:
795
AN:
152156
Hom.:
5
Cov.:
33
AF XY:
0.00531
AC XY:
395
AN XY:
74406
show subpopulations
Gnomad4 AFR
AF:
0.00123
Gnomad4 AMR
AF:
0.00464
Gnomad4 ASJ
AF:
0.0150
Gnomad4 EAS
AF:
0.00407
Gnomad4 SAS
AF:
0.0162
Gnomad4 FIN
AF:
0.000377
Gnomad4 NFE
AF:
0.00718
Gnomad4 OTH
AF:
0.00521
Alfa
AF:
0.00401
Hom.:
1
Bravo
AF:
0.00519
Asia WGS
AF:
0.00577
AC:
20
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Benign, criteria provided, single submitterclinical testingGeneDxFeb 08, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Oct 02, 2014- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsDec 30, 2019- -
not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2024KCNT1: BP4, BP7, BS1, BS2 -
Developmental and epileptic encephalopathy, 14;C3554306:Autosomal dominant nocturnal frontal lobe epilepsy 5 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsMay 17, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Developmental and epileptic encephalopathy, 14 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabMar 15, 2022- -
Autosomal dominant nocturnal frontal lobe epilepsy 5 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabMar 15, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
2.3
DANN
Benign
0.80

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139034501; hg19: chr9-138594134; COSMIC: COSV100039855; COSMIC: COSV100039855; API